Suyoun Chung
OncoTherapy Science (Japan)(JP)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer, Lipids, and Metabolism, FOXO transcription factor regulation, Peroxisome Proliferator-Activated Receptors, Prostate Cancer Treatment and Research
Most-Cited Works
- → Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility(2010)286 cited
- → Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer(2007)257 cited
- → A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population(2010)215 cited
- → Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism(2009)200 cited
- → Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer(2012)146 cited
- → Polypeptide N-acetylgalactosaminyltransferase 6 Disrupts Mammary Acinar Morphogenesis through O-glycosylation of Fibronectin(2011)102 cited
- → EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth(2006)71 cited
- → Involvement of the Tubulin Tyrosine Ligase-Like Family Member 4 Polyglutamylase in PELP1 Polyglutamylation and Chromatin Remodeling in Pancreatic Cancer Cells(2010)59 cited
- → Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer(2016)54 cited
- → Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy(2015)53 cited